Emerging Issues in Gram-Negative Bacterial Resistance: An Update for the Practicing Clinician

Mayo Clinic Proceedings

Volumn 90, Issue 3, 2015, Pages 395-403

  Vasoo, Shawn ^a,b   Barreto, Jason N ^a   Tosh, Pritish K ^a  

^a MAYO CLINIC   (United States)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEALTH; HUMAN; INCIDENCE; INFECTION CONTROL; PROCEDURES;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; GLOBAL HEALTH; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; INFECTION CONTROL;

EID: 84928429317     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.12.002     Document Type: Review

References (32)

1. S. Borgia, O. Lastovetska, D. Richardson, and et al. Outbreak of carbapenem-resistant enterobacteriaceae containing blaNDM-1, Ontario, Canada Clin Infect Dis 55 11 2012 e109 e117
2. T.R. Walsh, J. Weeks, D.M. Livermore, and M.A. Toleman Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study Lancet Infect Dis 11 5 2011 355 362
3. E.S. Snitkin, A.M. Zelazny, P.J. Thomas, and et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing Sci Transl Med 4 148 2012 148ra116
4. S.Y. Won, L.S. Munoz-Price, K. Lolans, and et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae Clin Infect Dis 53 6 2011 532 540
5. L.S. Munoz-Price, L. Poirel, R.A. Bonomo, and et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases Lancet Infect Dis 13 9 2013 785 796
6. P. Nordmann, and L. Poirel The difficult-to-control spread of carbapenemase producers in Enterobacteriaceae worldwide Clin Microbiol Infect 20 9 2014 821 830
7. T. Gottesman, O. Agmon, O. Shwartz, and M. Dan Household transmission of carbapenemase-producing Klebsiella pneumoniae Emerg Infect Dis 14 5 2008 859 860
8. M.E. Falagas, G.S. Tansarli, D.E. Karageorgopoulos, and K.Z. Vardakas Deaths attributable to carbapenem-resistant Enterobacteriaceae infections Emerg Infect Dis 20 7 2014 1170 1175
9. O. Zarkotou, S. Pournaras, P. Tselioti, and et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment Clin Microbiol Infect 17 12 2011 1798 1803
10. R. Smith, and J. Coast The true cost of antimicrobial resistance BMJ 346 2013 f1493
11. S.Y. Lee, S. Kotapati, J.L. Kuti, C.H. Nightingale, and D.P. Nicolau Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study Infect Control Hosp Epidemiol 27 11 2006 1226 1232
12. Freisinger F, O'Donnell J, Mishra N. Economic impact of a multi-drug resistant (MDR) KPC-possessing Klebsiella pneumoniae (KP) outbreak. In: Proceedings from the Infectious Diseases Society of America (IDSA) 45th Annual Meeting; October 4-7, 2007; San Diego, CA. Abstract 483.
13. P.D. Tamma, S.C. Girdwood, R. Gopaul, and et al. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae Clin Infect Dis 57 6 2013 781 788
14. M. Alvarez, J.H. Tran, N. Chow, and G.A. Jacoby Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States Antimicrob Agents Chemother 48 2 2004 533 537
15. G.A. Jacoby AmpC β-lactamases Clin Microb Rev 22 1 2009 161 182
16. A.Y. Peleg, and D.C. Hooper Hospital-acquired infections due to gram-negative bacteria N Engl J Med 362 19 2010 1804 1813
17. L.S. Tzouvelekis, A. Markogiannakis, M. Psichogiou, P.T. Tassios, and G.L. Daikos Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions Clin Microb Rev 25 4 2012 682 707
18. P. Kopterides, P.K. Koletsi, A. Michalopoulos, and M.E. Falagas Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates Int J Antimicrob Agents 30 5 2007 409 414
19. Vasoo S, Cunningham SA, Kohner PC, et al. In vitro activity of avibactam in combination with ceftazidime or aztreonam against a large, contemporary collection of carbapenemase-producing gram-negative bacilli. In: Proceedings and abstracts of the 54th Annual ICAAC Meeting; September 5-9, 2014; Washington, DC. Abstract D-886a.
20. S. Vasoo, S.A. Cunningham, P.C. Kohner, and et al. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli J Clin Microbiol 51 9 2013 3097 3101
21. M. Tumbarello, P. Viale, C. Viscoli, and et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy Clin Infect Dis 55 7 2012 943 950
22. M.E. Falagas, G.S. Tansarli, K. Ikawa, and K.Z. Vardakas Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis Clin Infect Dis 56 2 2013 272 282
23. I.I. Balkan, G. Aygun, S. Aydin, and et al. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival Int J Infect Dis 26 2014 51 56
24. X. Wang, F. Zhang, C. Zhao, and et al. In vitro activities of ceftazidime-avibactam and aztreonam-avibactam against 372 Gram-negative bacilli collected in 2011 and 2012 from 11 teaching hospitals in China Antimicrob Agents Chemother 58 3 2014 1774 1778
25. D.M. Livermore, S. Mushtaq, M. Warner, and et al. Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae Antimicrob Agents Chemother 55 1 2011 390 394
26. T.B. Giblin, R.L. Sinkowitz-Cochran, P.L. Harris, and et al. Clinicians' perceptions of the problem of antimicrobial resistance in health care facilities Arch Intern Med 164 15 2004 1662 1668
27. L.S. Munoz-Price, M.K. Hayden, K. Lolans, and et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital Infect Control Hosp Epidemiol 31 4 2010 341 347
28. M. Heller, P.A. Thompson, M.H. Loock, A. Sawchuk, and D.M. Guerrero Variability of adenosine triphosphate-based bioluminescence assay readings among drug-resistant pathogens Infect Control Hosp Epidemiol 33 12 2012 1286 1288
29. J.A. Navio, M. Garcia-Gomez, M.A. Pradera, and J. Fuentes Oxidation of 6- and 8-methylquinolines upon UV-illumination in the presence of a powder of TiO2 photocatalyst Photochem Photobiol Sci 1 2 2002 133 135
30. J.A. Otter, M. Cummins, F. Ahmad, C. van Tonder, and Y.J. Drabu Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination J Hosp Infect 67 2 2007 182 188
31. M. Souli, I. Galani, D. Plachouras, and et al. Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates J Antimicrob Chemother 68 4 2013 852 857
32. A. Huttner, S. Harbarth, J. Carlet, and et al. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum Antimicrob Resist Infect Control 2 2013 31